UK Establishes Landmark Independent Centre to Examine Gambling Harms Through Coordinated Research
The UK has launched its largest independent gambling harms research centre, the Gambling Harms Research UK Evidence Centre, which operates under the statutory Gambling Levy and receives oversight from UK Research and Innovation. Led by the University of Glasgow in partnership with King’s College London, the University of Sheffield and Swansea University, the centre directs attention toward the causes, prevention strategies and treatment approaches associated with gambling-related harms while incorporating perspectives from individuals who have experienced those harms directly. This development represents a clear departure from previous reliance on industry-supported investigations and instead aligns with regulatory priorities outlined in the 2023 Gambling White Paper. Funding arrives through the statutory levy mechanism, which channels resources away from operator contributions and toward publicly overseen academic programs. Observers note that the structure positions the centre to generate evidence that regulatory bodies and policymakers can apply without concerns over commercial influence.Partnership Structure and Operational Scope
Researchers at the University of Glasgow coordinate activities across the partner institutions, drawing on established expertise in public health, psychology, economics and social policy. The collaboration allows each university to contribute specialised knowledge while the centre maintains a unified research agenda focused on measurable outcomes. Data collection will examine prevalence patterns, risk factors and intervention effectiveness across diverse population groups.
The centre integrates input from people with lived experience at multiple stages, including study design, data interpretation and dissemination of findings. This approach ensures research questions reflect real-world conditions rather than purely theoretical frameworks. Teams plan to publish results through peer-reviewed channels and policy briefings that reach government departments and service providers.Funding Model and Regulatory Alignment
Resources come exclusively from the statutory Gambling Levy, which replaces earlier voluntary arrangements and places allocation decisions under UK Research and Innovation oversight. This model removes direct financial links between operators and research teams, addressing longstanding concerns about potential bias in earlier studies. The 2023 Gambling White Paper explicitly called for such independence, and the new centre operationalises that recommendation through formal governance structures.
UK Research and Innovation manages the overall programme, setting performance indicators that emphasise transparency and reproducibility. Annual reports will detail project milestones, budget utilisation and emerging evidence, giving stakeholders clear visibility into progress. Those involved expect the first major outputs to appear within eighteen months, covering baseline prevalence data and pilot prevention initiatives.Research Priorities and Lived-Experience Integration
Initial workstreams target three interconnected areas: identifying upstream causes that lead individuals into harmful gambling patterns, evaluating prevention measures that reach at-risk groups before problems escalate, and testing treatment protocols that improve recovery rates. Cross-disciplinary teams combine quantitative analysis of transaction and health records with qualitative insights gathered through structured consultations with affected individuals and their families.
People who have experienced gambling harms participate in advisory panels that review protocols and suggest refinements. Their contributions shape recruitment strategies for studies and help translate findings into accessible language for support services. This participatory element distinguishes the centre from earlier projects that sometimes overlooked service-user perspectives during design phases.Anticipated Contributions to Policy and Practice
Evidence generated by the centre is expected to inform future updates to licensing conditions, public health campaigns and NHS service commissioning. Policymakers gain access to independent datasets that track trends over time and compare outcomes across different regulatory environments. Service providers can then adapt interventions based on tested approaches rather than assumptions.
By May 2026, several longitudinal studies will have collected multiple waves of data, enabling more robust conclusions about which interventions produce sustained reductions in harm. The centre’s governance board includes representatives from academia, public health agencies and regulatory bodies, ensuring findings reach decision-makers who can implement changes at scale.